These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3100909)

  • 1. Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Passeri M; Zuppi P; Sambo P; Tofani A
    Metabolism; 1987 Feb; 36(2):105-9. PubMed ID: 3100909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity.
    De Marinis L; Mancini A; Folli G; D'Amico C; Corsello SM; Sciuto R; Tofani A; Sambo P; Barbarino A
    Neuroendocrinology; 1989 Nov; 50(5):529-32. PubMed ID: 2558324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
    Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    De Marinis L; Mancini A; D'Amico C; Zuppi P; Tofani A; Della Casa S; Saporosi A; Sambo P; Fiumara C; Calabró F
    Psychoneuroendocrinology; 1991; 16(6):499-504. PubMed ID: 1811245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.
    Mancini A; Bianchi A; Tacchino RM; Perrelli M; Milardi D; Gentilella R; Giampietro A; Fusco A; Valle D; De Marinis L
    Metabolism; 2001 Apr; 50(4):382-6. PubMed ID: 11288030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male.
    Tomasi PA; Fanciulli G; Palermo M; Pala A; Demontis MA; Delitala G
    Horm Metab Res; 1998 Jan; 30(1):34-6. PubMed ID: 9503036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
    Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
    J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
    Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB
    Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects.
    Losa M; Huss R; König A; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):473-80. PubMed ID: 3092529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.
    Guido M; Romualdi D; Mancini A; Lattanzi F; Villa P; Barini A; Lanzone A; De Marinis L
    Fertil Steril; 2002 Nov; 78(5):994-1000. PubMed ID: 12413983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
    J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of growth hormone-releasing hormone on pentagastrin-induced growth hormone release in normal subjects.
    Garcia-Rojas JF; Mangas A; Barba A; Millan J; Dieguez C; Zamora E
    J Endocrinol Invest; 1991 Mar; 14(3):241-4. PubMed ID: 2071825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sex and age on pyridostigmine potentiation of growth hormone-releasing hormone-induced growth hormone release.
    Corsello SM; Tofani A; Della Casa S; Rota CA; Sciuto R; Colasanti S; Barini A; Barbarino A
    Neuroendocrinology; 1992 Aug; 56(2):208-13. PubMed ID: 1407375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.